Criteo Stock Price, News & Analysis

LiveRamp (NYSE: RAMP) reported a strong financial performance for Q2 fiscal 2022, with total revenue increasing by 22% to $127 million. Subscription revenue rose by 23% to $105 million, constituting 83% of total revenue. GAAP gross margin expanded to 72%, while non-GAAP gross margin reached 77%. The company achieved a record operating performance, adding 15 new direct subscription customers, bringing the total to 870. LiveRamp’s outlook for fiscal 2022 has been raised, expecting revenue of $525 million and non-GAAP operating income of $40 million.

Tilak Healthcare has successfully completed a €7 million fundraising round led by Elaia with participation from Swen Capital Partners, Matmut Innovation, and the iBionext Growth Fund. This funding will support the international rollout of its mobile vision testing platform, OdySight, which has already been adopted by nearly 20% of retinologists in France. The platform, designed for remote monitoring of visual health, aims to address the needs of the 2.2 billion people with vision impairment globally.

Criteo S.A. (NASDAQ: CRTO) is set to announce its financial results for Q3 2021 on November 3, 2021. CEO Megan Clarken and CFO Sarah Glickman will host a conference call at 8:00 AM ET, alongside Chief Product Officer Todd Parsons. U.S. callers can join at +1 855 209 8212, while international callers can access the call at +1 412 317 0788 or +33 1 76 74 05 02. The call will also be streamed live via the Criteo website, with a replay available afterward.

Shippeo, a leader in real-time transportation visibility, reported a remarkable 103% year-on-year growth in subscription revenues and a 181% net retention rate. The company welcomed numerous international brands, including Coca-Cola HBC and Nexans, expanding its global footprint. Shippeo's employee count has increased to over 230, with plans to double its workforce by the end of 2021. The company maintains a 0% customer churn rate, emphasizing enhanced product offerings and partnerships with leading supply chain firms.

bluebird bio has announced a tax-free spin-off of its oncology programs into 2seventy bio, with a completion timeline of early November 2021. Shareholders will receive 1 share of 2seventy bio for every 3 shares of bluebird bio owned. The company expects approximately $1.0B in cash reserves at the time of separation, funding 2seventy bio with $480M. Two new board members, Najoh Tita-Reid and Sarah Glickman, have been appointed to strengthen leadership. The separation is designed to enhance operational focus and shareholder value.

Optimove, a CRM marketing leader, secured a $75 million investment from Summit Partners aimed at enhancing M&A strategy, hiring, and expanding its SaaS platform for customer engagement and retention. This funding will enable Optimove to accelerate growth, as it continues to maintain healthy profit margins while generating over 40% revenue growth in the past year. The company currently sends more than 23 billion marketing messages annually and serves over 500 brands globally. Summit Partners' executives will join Optimove's Board of Directors.

InMobi announces the appointment of Joe Esposito to lead its new Agency Partnerships team, aiming to enhance ties with major agencies in North America. Reporting to Greg Archibald, Esposito brings nearly 20 years of digital marketing experience, particularly from his roles in Criteo and Rio SEO. His expertise lies in fostering agency relationships and driving innovation in demand and supply-side solutions. Esposito's leadership is expected to support InMobi's growth strategy while addressing current industry challenges faced by agencies.

Criteo S.A. (NASDAQ: CRTO) announced the appointment of Manuela Montagnana as Chief People Officer, succeeding Denis Collin. Montagnana, with over 20 years in global HR leadership, will guide talent strategy for the company's workforce of more than 2,500 employees. Previously, she served at Compass, leading transformational HR projects. Her focus will be on promoting inclusivity and employee engagement while ensuring Criteo attracts and retains top talent. CEO Megan Clarken expressed enthusiasm for Montagnana's role in enhancing the company's people-centric culture in a hybrid working environment.

Marpipe has successfully concluded an $8 million Series A funding round, led by Stage 2 Capital and supported by notable investors including ValueStream Ventures and Samsung. This funding follows a $2 million seed round in 2019 and aims to enhance Marpipe's capabilities in automated creative testing. The company plans to expand its team significantly and centralize creative data for brands, addressing the growing demand for effective ad testing solutions. Marpipe's CEO, Dan Pantelo, emphasizes the need for a tech stack that empowers creatives to optimize ad performance.